The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas
Open accessAbstract
Purpose Radiotherapy (XRT) for spine sarcomas is constrained by spinal cord, nerve, and viscera tolerance. Negative surgical margins are uncommon; hence, doses of ≥ 66 Gy are recommended. A Phase II clinical trial evaluated high dose photon/proton XRT for spine sarcomas. Materials/Methods Eligible patients had non-metastatic, thoracic, lumbar, and/or sacral spine/paraspinal sarcomas. Treatment included pre- and/or post-op photon/proton XRT +/- radical resection; patients with osteosarcoma and Ewing's sarcoma received chemotherapy. Shrinking fields delivered 50.4 cobalt Gray equivalent (GyRBE) to subclinical disease, 70.2 GyRBE to microscopic disease in the tumor bed, and 77.4 GyRBE to gross disease at 1.8 GyRBE q.d. Doses were reduced for radiosensitive histologies, concurrent chemoradiation, or when diabetes or autoimmune disease present. Spinal cord dose was limited to 63/54 GyRBE to surface/center. Intra-operative boost doses of 7.5-10 Gy could be given by dural plaque. Results 50 patients (29 chordoma, 14 chondrosarcoma, 7 other) underwent gross total (n=25) or subtotal (n=12) resection or biopsy (n=13). With 48 month median follow-up, five-year actuarial local control, recurrence-free survival, and overall survival are: 78%, 63%, and 87% respectively. Two of 36 (5.6%) patients treated for primary versus 7/14 (50%) for recurrent tumor developed local recurrence, p<0.001. Five patients developed late radiation-associated complications; no myelopathy developed but three sacral neuropathies appeared following 77.12-77.4 GyRBE. Conclusions Local control with this treatment is high in patients radiated at the time of primary presentation. Spinal cord dose constraints appear to be safe. Sacral nerves receiving 77.12-77.4 GyRBE are at risk for late toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., Steinberg, S. M., Merino, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.197 · Cited by 1,541
Self-citationEvans, H. L., Ayala, A. G., & Romsdahl, M. M. (1977) · Cancer · doi:10.1002/1097-0142(197708)40:2<818::aid-cncr2820400234>3.0.co;2-b · Cited by 987
Radiation response of the central nervous system
Schultheiss, T. E., Kun, L. E., Ang, K. K., & Stephens, L. C. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00655-5 · Cited by 653
Goitein, M., Abrams, M., Rowell, D., Pollari, H., & Wiles, J. (1983) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(83)90003-2 · Cited by 392
Austin-Seymour, M., Munzenrider, J., Goitein, M., Verhey, L., Urie, M., Gentry, R., Birnbaum, S., Ruotolo, D., McManus, P., Skates, S., et al. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.70.1.0013 · Cited by 306
Self-citationEfficacy and Safety of Carbon Ion Radiotherapy in Bone and Soft Tissue Sarcomas
Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J.-E., Miyamoto, T., Kato, H., Yamada, S., Morita, S., Yoshikawa, K., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.050 · Cited by 289
Compensating for heterogeneities in proton radiation therapy
Urie, M., Goitein, M., & Wagner, M. (1984) · Physics in Medicine and Biology · doi:10.1088/0031-9155/29/5/008 · Cited by 183
Weber, D. C., Trofimov, A. V., DeLaney, T. F., & Bortfeld, T. R. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.028 · Cited by 122
Self-citationCauda equina tolerance to high-dose fractionated irradiation
Pieters, R. S., Niemierko, A., Fullerton, B. C., & Munzenrider, J. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.04.019 · Cited by 57
Cervical spine osteosarcoma treated with carbon-ion radiotherapy
Imai, R., Kamada, T., Tsuji, H., Tsujii, H., Tsuburai, Y., & Tatezaki, S. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70978-0 · Cited by 38
Cited by
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hogendoorn, P. C. W., Athanasou, N., Bielack, S., De Alava, E., Dei Tos, A. P., Ferrari, S., Gelderblom, H., Grimer, R., Sundby Hall, K., Hassan, B., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq223 · Cited by 718
Stacchiotti, S., & Sommer, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71190-8 · Cited by 501
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., Rose, P. S., Folpe, A. L., & Laack, N. N. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.01.015 · Cited by 298
Proton vs carbon ion beams in the definitive radiation treatment of cancer patients
Suit, H., DeLaney, T., Goldberg, S., Paganetti, H., Clasie, B., Gerweck, L., Niemierko, A., Hall, E., Flanz, J., Hallman, J., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.015 · Cited by 290
Self-citationPhase II Study of Imatinib in Advanced Chordoma
Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., Stupp, R., Bertuzzi, A., Tamborini, E., Pilotti, S., Messina, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.3656 · Cited by 276
Metadata
- Authors
- DeLaney, T. F., Liebsch, N. J., Pedlow, F. X., Adams, J., Dean, S., Yeap, B. Y., McManus, P., Rosenberg, A. E., Nielsen, G. P., Harmon, D. C., Spiro, I. J., Raskin, K. A., Suit, H. D., Yoon, S. S., & Hornicek, F. J.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 74
- Issue
- 3
- Pages
- 732-739
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W1971742491
- Cited by
- 264
- References
- 10
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas. https://app.cochat.ai/papers/10.1016/j.ijrobp.2008.08.058
- The paper
- DeLaney, T. F., Liebsch, N. J., Pedlow, F. X., Adams, J., Dean, S., Yeap, B. Y., McManus, P., Rosenberg, A. E., Nielsen, G. P., Harmon, D. C., Spiro, I. J., Raskin, K. A., Suit, H. D., Yoon, S. S., & Hornicek, F. J. (2009). Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2008.08.058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.